Pharma Focus Asia

Renaissance Lakewood Expands Laboratory Facilities in New Jersey, USA

Introduction:

Renaissance Lakewood expands the capabilities of quality control spray/particulate laboratory, along with significant upgrades to their analytical and formulation research and development laboratories in New Jersey, USA

Features:

The facilities upgrade commenced in 2021 and primarily involving relocation of the the existing laboratories from different areas within the Renaissance campus to a recently completed science building and office space spanning 31,000 square feet at 1220 Paco Way.

The multi-million-dollar investment in cutting-edge technology and equipment forms an integral component of comprehensive renovation and expansion plan for the main Renaissance campus. 

These new cutting-edge laboratory spaces has equipped with the essential tools and infrastructure to make a substantial impact on product development and research initiatives.

The new quality control laboratory includes a separate room compliant with the drug enforcement administration (DEA) regulations, specially designated for the housing of cages. 

Furthermore, to enhance efficiency and streamline processes, the facility boasts a segregated sample drop-off area, a dedicated glassware washroom, and an isolated dark room optimised for conducting light-sensitive analyses.

This project will result in the construction of a total of four new buildings, with the entire endeavour anticipated to be completed by the first quarter of 2024.

Specifications:

Name   Renaissance Lakewood
Type   Expansion
Year   2024

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference